ArticleWellcome open research2018

High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study).

Fiona V Cresswell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.